BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Giacaman A, Henriquez W, Tolosa G, Prado A, Jerez R, Reveco Y, Martínez C, Baumert C, Rodríguez B, Sanhueza B, José Orellana J, Inostroza J. Hematological abnormalities in immunosuppressed patients with COVID-19: evidence from a single center. A cross sectional study. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108862] [Reference Citation Analysis]
2 Saiag E, Grupper A, Avivi I, Elkayam O, Ram R, Herishanu Y, Cohen Y, Perry C, Furer V, Katchman H, Rabinowich L, Ben-yehoyada M, Halperin T, Baruch R, Goldshmidt H, Hagin D, Ben-ami R, Sprecher E, Bomze D. The effect of a third-dose BNT162b2 vaccine on anti-sars-cov-2 antibody levels in immunosuppressed patients. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.002] [Reference Citation Analysis]
3 Clémenceau B, Guillaume T, Coste-burel M, Peterlin P, Garnier A, Le Bourgeois A, Jullien M, Ollier J, Grain A, Béné MC, Vié H, Chevallier P. SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine. Vaccines 2022;10:448. [DOI: 10.3390/vaccines10030448] [Reference Citation Analysis]
4 Plymate LC, Pepper G, Krist MP, Koelle DM. Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab. J Transl Autoimmun 2021;4:100114. [PMID: 34426798 DOI: 10.1016/j.jtauto.2021.100114] [Reference Citation Analysis]
5 Wagner A, Garner-spitzer E, Schötta A, Orola M, Wessely A, Zwazl I, Ohradanova-repic A, Weseslindtner L, Tajti G, Gebetsberger L, Kratzer B, Tomosel E, Kutschera M, Tobudic S, Pickl WF, Kundi M, Stockinger H, Novacek G, Reinisch W, Zielinski C, Wiedermann U. SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease. Front Immunol 2022;13:889138. [DOI: 10.3389/fimmu.2022.889138] [Reference Citation Analysis]
6 Lupo-stanghellini MT, Di Cosimo S, Costantini M, Monti S, Mantegazza R, Mantovani A, Salvarani C, Zinzani PL, Inglese M, Ciceri F, Apolone G, Ciliberto G, Baldanti F, Morrone A, Sinno V, Locatelli F, Notari S, Turola E, Giannarelli D, Silvestris N. mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients. Front Oncol 2022;12:855723. [DOI: 10.3389/fonc.2022.855723] [Reference Citation Analysis]
7 Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Chen P, Söderdahl G, Österborg A, Smith CIE, Wullimann D, Vesterbacka J, Lindgren G, Blixt L, Friman G, Wahren-Borgström E, Nordlander A, Gomez AC, Akber M, Valentini D, Norlin AC, Thalme A, Bogdanovic G, Muschiol S, Nilsson P, Hober S, Loré K, Chen MS, Buggert M, Ljunggren HG, Ljungman P, Aleman S; COVAXID-collaborator group (shown separately). Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. EBioMedicine 2021;74:103705. [PMID: 34861491 DOI: 10.1016/j.ebiom.2021.103705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect 2022:S0163-4453(21)00658-7. [PMID: 34982962 DOI: 10.1016/j.jinf.2021.12.035] [Reference Citation Analysis]
9 Ko KKK, Yingtaweesittikul H, Tan TT, Wijaya L, Cao DY, Goh SS, Abdul Rahman NB, Chan KXL, Tay HM, Sim JHC, Chan KS, Oon LLE, Nagarajan N, Suphavilai C. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts. Microbiol Spectr 2022;:e0079122. [PMID: 35543562 DOI: 10.1128/spectrum.00791-22] [Reference Citation Analysis]